Novocure said Tuesday that a cybersecurity incident in mid-August involving unauthorized access to certain information systems exposed internal records belonging to more than 1,400 U.S. patients. The oncology company said it activated its response plan, put containment measures in place, and opened an internal investigation.
The number is small compared with the health care breaches that made headlines this year. What makes it worth a patient's attention is the company it keeps. Over roughly the past three months, cyberattacks have hit device makers including Abbott, Stryker, Medtronic, and Boston Scientific, drugmaker Novo Nordisk, and drug delivery equipment supplier West Pharmaceutical Services.
